Alzheimer’s disease and oxygen radicals: new insights
- 1 February 2002
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 63 (4) , 563-567
- https://doi.org/10.1016/s0006-2952(01)00919-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The isoprostanes in biology and medicineTrends in Endocrinology & Metabolism, 2001
- Transgenic mouse models of Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Oxidative stress in Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Evaluation of Serum-Lipid-Related Cardiovascular Risk Factors in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative StressJournal of Neurochemistry, 1998
- Increased Peroxidation and Reduced Antioxidant Enzyme Activity in Alzheimer's DiseaseExperimental Neurology, 1998
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- No evidence for systemic oxidant stress in Parkinson's or Alzheimer's diseaseMovement Disorders, 1995